AIIMS Delhi, Blockchain For Impact to advance biomedical innovation in India

Posted on by Vividh Bharathi

New Delhi, Dec 20 (IANS) The All India Institute of Medical Sciences (AIIMS) Delhi on Friday announced a collaboration with Blockchain For Impact (BFI) to enhance biomedical research and innovation in the public health sector.

As per the Memorandum of Understanding (MoU) signed by the two organisations, BFI will support a project exploring genetic and epigenetic factors to identify potential marks for recurrent urinary tract infections.

Recurrent urinary tract infections (rUTI) represent a major healthcare and economic burden with a significant impact on patient’s morbidity and quality of life.

The project, led by Dr. Sarita Mohapatra, Additional Professor, Department of Microbiology at AIIMS Delhi is funded under the BFI-BIOME Medical INI Grant Programme, which supports Medical Institutes of National Importance (INIs) through the Blockchain For Impact Biomedical Virtual Network (BFI-BIOME).

This network, created by BFI, aims to foster multisectoral collaboration, support upstream and deep science research, and drive innovation to strengthen biomedical research in India.

AIIMS Delhi is home to 25 clinical departments and four super-specialty centers. Its research initiatives have made significant contributions to combating infectious diseases such as leprosy, malaria, and tuberculosis, as well as non-communicable diseases like diabetes, and more.

The partnership with AIIMS Delhi aligns perfectly with BFI’s mission to accelerate transformative healthcare solutions through cutting-edge biomedical innovation.

“At AIIMS New Delhi, we are committed to advancing healthcare innovation through cutting-edge research and technology. The support from the BFI-BIOME Medical INI Grant Programme enables us to explore new frontiers in medical science, empowering our faculty and researchers to make transformative contributions to global healthcare,” said Dr. M Srinivas, Director of AIIMS Delhi.

“The BFI-BIOME initiative represents a paradigm shift by fostering collaboration between leading biomedical researchers, clinicians, and innovators to pioneer the next generation of health interventions. Partnering with AIIMS Delhi is a step in the right direction for us. It reinforces our commitment to strengthening the healthcare ecosystem in India,” added Sandeep Nailwal, the visionary founder of BFI.

This partnership between AIIMS Delhi with BFI marks a pivotal milestone in the BFI-BIOME Network Programme’s ongoing efforts to advance biomedical research and innovation in India.

By fostering innovation and equitable access, BFI aims to create a transformative healthcare ecosystem that addresses the nation’s most pressing medical challenges.

–IANS

rvt/

Related Posts

CureFit posts Rs 888 crore loss in FY24

New Delhi, Dec 17 (IANS) Fitness startup Curefit’s consolidated loss has increased by 42 per cent to Rs 888.5 crore in FY24 from Rs 625.5 crore in FY23.

The company’s EBITDA loss surged by 123.4 per cent to Rs 587.97 crore in FY24 from Rs 263.2 crore in FY23.

The reason for the increase in the company’s loss in the last financial year is the high cash burn. Curefit’s advertising and promotion expenditure has increased by 40.67 per cent year-on-year (YoY) basis to Rs 188.5 crore in FY24 from Rs 134 crore in FY23.

At the same time, the company’s expenditure on legal and professional services in the last financial year has increased by 56.62 per cent from Rs 79.3 crore in FY23 to Rs 124.2 crore in FY24.

Curefit’s expenditure on employees has come down by 5.62 per cent to Rs 324 crore in the last financial year. This is due to workforce restructuring and layoffs in FY24. Curefit slashed around 120 jobs in January 2024 in a restructuring exercise. These job cuts impacted workers across the company’s brands like Sugar.fit, Carefit, Cultfit, among others.

Curefit’s operating income has increased by 33.6 per cent to Rs 926.6 crore in FY24 from Rs 693.7 crore in FY23. Out of this, an income of Rs 663.1 crore has come from services, which is 46.58 per cent more than Rs 452.4 crore in FY 23.

Apart from this, income from the sale of products has increased by 8.13 per cent to Rs 256.7 crore from Rs 237.4 crore in FY23.

Founded in 2016 by Mukesh Bansal and Ankit Nagori, Curefit runs the physical fitness platform Cultfit, mental health platform Mindfit, primary care vertical Care.fit, etc. According to reports, Curefit has raised more than $750 million in funding so far. Its investors include Accel, Temasek, Kalaari Capital, and others.

–IANS

avs/vd

India glucose monitoring market to grow at 2pc CAGR by 2033: Report

New Delhi, Dec 16 (IANS) Amid the growing prevalence of diabetes in India, the glucose monitoring market in the country is forecast to grow at a 2 per cent compound annual growth rate (CAGR) during 2024-33, according to a report on Monday.

The report by GlobalData, a data and analytics company, said that the growing prevalence of diabetes in India, combined with limited access to reliable monitoring tools, presents a significant public health challenge.

Effective glucose monitoring is crucial for disease management, yet affordability and accuracy remain key barriers.

In 2024, India’s glucose monitoring market accounted for about 10 per cent of the Asia-Pacific (APAC) market. The report said this reflects the growing focus on affordable and innovative solutions tailored to local needs.

“Despite the growing availability of glucose monitoring solutions in India, there remain significant gaps in affordability, user education, and accessibility, particularly in rural areas. Locally manufactured devices can help bridge these gaps, but broader efforts in education and support systems are vital for effective diabetes management,” said Kanchan Chauhan, Medical Devices Analyst at GlobalData.

“India’s diabetes burden underscores the urgency of addressing gaps in care delivery and promoting consistent disease management. Strengthening healthcare infrastructure and raising awareness at the community level will be key to transforming diabetes management and improving long-term health outcomes across the country,” Chauhan said.

A recent report by ResearchAndMarkets.com showed that the glucose monitoring devices market in India was valued at $366.53 million in 2024. The report said it is anticipated to project impressive growth in the forecast period with a CAGR of 7.08 per cent through 2030

It further noted that Maharashtra and Gujarat are expected to exert a significant influence over the glucose monitoring devices market due to a higher prevalence of diabetes, a more developed healthcare infrastructure. An increasing awareness of the importance of self-monitoring glucose devices also contributed to the higher adoption.

–IANS

rvt/

Cambodia bans energy drinks at schools

Phnom Penh, Dec 10 (IANS) Cambodia on Tuesday banned energy drinks at schools as the Southeast Asian country has seen a significant rise in diabetes among young people.

Deputy Prime Minister and Minister of Education, Youth and Sport Hang Chuon Naron said the move was aimed at preventing the risk of non-communicable diseases, especially diabetes, which was caused by the consumption of sugary and energy drinks.

“The consumption, distribution, sale, and advertisement of all kinds of energy drinks in and around schools’ campuses are strictly prohibited,” he said in a directive, Xinhua news agency reported.

He said the prohibition was applied to all public and private educational institutions as well as technical education institutions across the country.

Naron advised all schools to remind students of the effects of having energy drinks when they gathered for the salutation of the national flag.

He also instructed the schools to seize energy drinks from sellers in and around the schools and terminate their stall rental contracts if they defied the ban.

The prohibition came hours after Cambodian Prime Minister Hun Manet said the kingdom has reported an increase in diabetes, advising the Ministry of Education, Youth and Sport to take action to prevent the disease among students.

“Some children consume up to three cans of sugary or energy drinks a day,” he said during a groundbreaking ceremony for the University of Health Sciences Hospital in Phnom Penh.

According to Minister of Health Chheang Ra, diabetes was a major cause of mortality in Cambodia.

He said while infectious diseases were once the primary cause of death in the country, non-communicable diseases currently accounted for more than half of fatalities.

The minister said four main types of non-communicable diseases are heart disease, diabetes, cancer, and chronic respiratory disease.

–IANS

as/